![Sana Alajmovic](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Sana Alajmovic was the founder of Sigrid Therapeutics AB, founded in 2014, and held the title of Chief Executive Officer & Director.
Ms. Alajmovic currently holds the position of Chief Executive Officer at Enzymatica AB, starting in 2026.
Aktive Positionen von Sana Alajmovic
| Unternehmen | Position | Beginn |
|---|---|---|
| ENZYMATICA AB | Vorstandsvorsitzender | 01.02.2026 |
Ehemalige bekannte Positionen von Sana Alajmovic
| Unternehmen | Position | Ende |
|---|---|---|
Sigrid Therapeutics AB
 Sigrid Therapeutics AB Pharmaceuticals: OtherHealth Technology Manufactures and sells dietary supplement products for blood sugar & weight management, glucose stabilizer and foods | Gründer | 31.01.2026 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
16
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Enzymatica AB
 Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases | Health Technology |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Pharmaceuticals: OtherHealth Technology Manufactures and sells dietary supplement products for blood sugar & weight management, glucose stabilizer and foods | Health Technology |
